LB-P8 high-dose: Clinical Trials

1 trial of LB-P8 high-dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow LB-P8 high-dose: new trials by email Literature Review of LB-P8 high-dose trials Research Report on LB-P8 high-dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
LB-P8 low-dose, LB-P8 high-dose, Placebo - Primary Sclerosing Cholangitis (PSC)
Phase 2RecruitingLISCure Biosciences872025-11-012025-10-24

Conditions studied

Cholangitis, Sclerosing (1)  ·  Cholestasis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Pruritus (1)

Sponsors

LISCure Biosciences (1)

Countries

United States (1)